Switch to: References

Add citations

You must login to add citations.
  1. Is Electroconvulsive Therapy (ECT) Ever Ethically Justified? If so, Under What Circumstances.Mary Stefanazzi - 2013 - HEC Forum 25 (1):79-94.
    The debate about ECT in Ireland in recent times has been vibrant and often polarised. The uniqueness of the Irish situation is that the psychiatric profession is protected by legislation whereby ECT treatment can be authorized by two consultant psychiatrists without the consent of the patient. This paper will consider if ECT is ever ethically justified, and if so, under what circumstances. The proposal is to investigate ECT from an ethical perspective with reference to the UNESCO Universal Declaration on Bioethics (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Deep Brain Stimulation as a Probative Biology: Scientific Inquiry and the Mosaic Device.Joseph J. Fins - 2012 - American Journal of Bioethics Neuroscience 3 (1):4-8.
    Building upon an earlier critique of the Food and Drug Adminstration (FDA) granting of a humanitarian device exemption for deep brain stimulation in treatment-resistant obsessive compulsive disorder, this article considers how we regulate and finance DBS. It suggests that these devices are mosaic in nature: both potentially therapeutic and probative and that their dual roles need to be appreciated to maximize their therapeutic and investigational potential.
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • They Might Retain Capacities to Consent But Do They Even Care?Laura Cabrera - 2011 - American Journal of Bioethics Neuroscience 2 (1):41-42.
    Dunn and colleagues (2011) present a balanced article, which makes the following important points about the use of deep brain stimulation (DBS) in the case of treatment-resistant major depression (...
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The Ethical Differences Between Psychiatric and Neurologic DBS: Smaller Than We Think?Matthis Synofzik & Jens Clausen - 2011 - American Journal of Bioethics Neuroscience 2 (1):37-39.
    Download  
     
    Export citation  
     
    Bookmark  
  • Should DBS for Psychiatric Disorders be Considered a Form of Psychosurgery? Ethical and Legal Considerations.Devan Stahl, Laura Cabrera & Tyler Gibb - 2018 - Science and Engineering Ethics 24 (4):1119-1142.
    Deep brain stimulation (DBS), a surgical procedure involving the implantation of electrodes in the brain, has rekindled the medical community’s interest in psychosurgery. Whereas many researchers argue DBS is substantially different from psychosurgery, we argue psychiatric DBS—though a much more precise and refined treatment than its predecessors—is nevertheless a form of psychosurgery, which raises both old and new ethical and legal concerns that have not been given proper attention. Learning from the ethical and regulatory failures of older forms of psychosurgery (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Factors Influencing Perceived Helpfulness and Participation in Innovative Research:A Pilot Study of Individuals with and without Mood Symptoms.Jane Paik Kim, Tenzin Tsungmey, Maryam Rostami, Sangeeta Mondal, Max Kasun & Laura Weiss Roberts - 2022 - Ethics and Behavior 32 (7):601-617.
    Little is known about how individuals with and without mood disorders perceive the inherent risks and helpfulness of participating in innovative psychiatric research, or about the factors that influence their willingness to participate. We conducted an online survey with 80 individuals (self-reported mood disorder [n = 25], self-reported good health [n = 55]) recruited via MTurk. We assessed respondents’ perceptions of risk and helpfulness in study vignettes associated with two innovative research projects (intravenous ketamine therapy and wearable devices), as well (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Patients’ Beliefs About Deep Brain Stimulation for Treatment-Resistant Depression.Ryan E. Lawrence, Catharine R. Kaufmann, Ravi B. DeSilva & Paul S. Appelbaum - 2018 - American Journal of Bioethics Neuroscience 9 (4):210-218.
    Deep brain stimulation is an experimental procedure for treatment-resistant depression. Some results show promise, but blinded trials had limited success. Ethical questions center on vulnerability: especially on whether depressed patients can weigh the risks and benefits effectively, whether depression causes “desperation,” and whether media portrayals create unrealistic hopes. We interviewed 24 psychiatric inpatients with treatment-resistant depression, qualitatively analyzing their comments. Most had minimal interest in deep brain stimulators. Some might consider them if their depression worsened, if alternatives were exhausted, or (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • Research Consent for Deep Brain Stimulation in Treatment-Resistant Depression: Balancing Risk With Patient Expectations.Nir Lipsman, Mary Pat McAndrews, Andres M. Lozano & Mark Bernstein - 2011 - American Journal of Bioethics Neuroscience 2 (1):39-41.
    Download  
     
    Export citation  
     
    Bookmark  
  • Brain Pioneers and Moral Entanglement: An Argument for Post‐trial Responsibilities in Neural‐Device Trials.Sara Goering, Andrew I. Brown & Eran Klein - 2024 - Hastings Center Report 54 (1):24-33.
    We argue that in implanted neurotechnology research, participants and researchers experience what Henry Richardson has called “moral entanglement.” Participants partially entrust researchers with access to their brains and thus to information that would otherwise be private, leading to created intimacies and special obligations of beneficence for researchers and research funding agencies. One of these obligations, we argue, is about continued access to beneficial technology once a trial ends. We make the case for moral entanglement in this context through exploration of (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Thinking Ahead on Deep Brain Stimulation: An Analysis of the Ethical Implications of a Developing Technology.Veronica Johansson, Martin Garwicz, Martin Kanje, Lena Halldenius & Jens Schouenborg - 2014 - American Journal of Bioethics Neuroscience 5 (1):24-33.
    Deep brain stimulation (DBS) is a developing technology. New generations of DBS technology are already in the pipeline, yet this particular fact has been largely ignored among ethicists interested in DBS. Focusing only on ethical concerns raised by the current DBS technology is, albeit necessary, not sufficient. Since current bioethical concerns raised by a specific technology could be quite different from the concerns it will raise a couple of years ahead, an ethical analysis should be sensitive to such alterations, or (...)
    Download  
     
    Export citation  
     
    Bookmark   22 citations  
  • Not-So-Straightforward Decisions to Keep or Explant a Device: When Does Neural Device Removal Become Patient Coercion?Frederic Gilbert, Paul Tubig & Alexander R. Harris - 2022 - American Journal of Bioethics Neuroscience 13 (4):230-232.
    In their article, Sankary et al. (2022) provided important preliminary findings on how research participants exiting from clinical trials engage in decisions related to the removal or post-trial us...
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Desperation May Affect Autonomy but Not Informed Consent.Teresa Swift - 2011 - American Journal of Bioethics Neuroscience 2 (1):45-46.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Including Appreciation and Voluntariness: The Other Two Elements of Decision-Making Capacity.Alessandro Manduca-Barone - 2011 - American Journal of Bioethics Neuroscience 2 (1):43-45.
    In the article “Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent,” Dunn and colleagues (2011) discuss the understanding and reasoning...
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance Between Risks and Benefits.Roger C. Ho & Melvyn W. Zhang - 2017 - Ethics and Behavior 27 (8):681-699.
    Previous research conducted in 1999 highlighted ethical concerns behind challenge studies inducing psychosis with ketamine and made recommendations to enhance ethical standards. Recently, a plethora of clinical trials have evaluated the efficacy of ketamine to treat mood disorders, which lead to complex ethical issues. Pharmaceutical companies and researchers hope to profit by developing patentable variations on ketamine for treating depression. Media have labeled ketamine as a “miracle” antidepressant. Some clinics offer expensive off-label use of ketamine to treat mood disorders. This (...)
    Download  
     
    Export citation  
     
    Bookmark